Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

USANA Health Sciences, Inc. USNA

Full chart Compare
Set alert

Price alert · USNA

All alert types
13.81 USD -1.06 (-7.13%)

Nov 4, 2026, 10:22 AM EST

12.68 Day range 14.39
12.57 52-week range 23.59
YTD
-29.65%
1 year
-32.80%

Financial health

Altman Z-Score

2.49 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E 33.5×
FY 2016: 15.0×FY 2017: 28.5×FY 2018: 22.0×FY 2019: 17.7×FY 2020: 13.1×FY 2021: 17.5×FY 2022: 14.8×FY 2023: 16.1×FY 2024: 16.2×FY 2025: 33.5×
FY 2016 5y median 16.2× FY 2025
P/S 0.4×
FY 2016: 1.5×FY 2017: 1.7×FY 2018: 2.3×FY 2019: 1.7×FY 2020: 1.4×FY 2021: 1.7×FY 2022: 1.0×FY 2023: 1.1×FY 2024: 0.8×FY 2025: 0.4×
FY 2016 5y median 1.0× FY 2025
P/B 0.7×
FY 2016: 4.6×FY 2017: 4.9×FY 2018: 7.1×FY 2019: 5.1×FY 2020: 3.7×FY 2021: 5.2×FY 2022: 2.4×FY 2023: 2.1×FY 2024: 1.3×FY 2025: 0.7×
FY 2016 5y median 2.1× FY 2025
P/FCF 42.4×
FY 2016: 14.4×FY 2017: 16.1×FY 2018: 19.7×FY 2019: 16.1×FY 2020: 11.2×FY 2021: 18.8×FY 2022: 11.0×FY 2023: 18.4×FY 2024: 13.4×FY 2025: 42.4×
FY 2016 5y median 18.4× FY 2025
EV/EBITDA 2.6×
FY 2016: 8.7×FY 2017: 10.2×FY 2018: 12.3×FY 2019: 9.3×FY 2020: 6.6×FY 2021: 9.4×FY 2022: 5.8×FY 2023: 5.8×FY 2024: 5.4×FY 2025: 2.6×
FY 2016 5y median 5.8× FY 2025
EV/Sales 0.2×
FY 2016: 1.3×FY 2017: 1.5×FY 2018: 2.2×FY 2019: 1.5×FY 2020: 1.2×FY 2021: 1.5×FY 2022: 0.8×FY 2023: 0.8×FY 2024: 0.6×FY 2025: 0.2×
FY 2016 5y median 0.8× FY 2025
FCF Yield 2.4%
FY 2016: 7.0%FY 2017: 6.2%FY 2018: 5.1%FY 2019: 6.2%FY 2020: 9.0%FY 2021: 5.3%FY 2022: 9.1%FY 2023: 5.4%FY 2024: 7.5%FY 2025: 2.4%
FY 2016 5y median 5.4% FY 2025

Profitability

Gross Margin 78.3%
FY 2016: 80.7%FY 2017: 81.3%FY 2018: 81.7%FY 2019: 81.0%FY 2020: 80.4%FY 2021: 80.5%FY 2022: 79.2%FY 2023: 79.4%FY 2024: 79.4%FY 2025: 78.3%
FY 2016 5y median 79.4% FY 2025
Operating Margin 5.5%
FY 2016: 13.8%FY 2017: 12.7%FY 2018: 15.8%FY 2019: 13.8%FY 2020: 15.6%FY 2021: 14.3%FY 2022: 10.8%FY 2023: 10.1%FY 2024: 7.8%FY 2025: 5.5%
FY 2016 5y median 10.1% FY 2025
Net Margin 1.2%
FY 2016: 9.9%FY 2017: 6.0%FY 2018: 10.6%FY 2019: 9.5%FY 2020: 11.0%FY 2021: 9.8%FY 2022: 6.9%FY 2023: 6.9%FY 2024: 4.9%FY 2025: 1.2%
FY 2016 5y median 6.9% FY 2025
ROE 2.0%
FY 2016: 30.8%FY 2017: 17.2%FY 2018: 32.3%FY 2019: 28.6%FY 2020: 28.2%FY 2021: 29.5%FY 2022: 16.0%FY 2023: 12.8%FY 2024: 7.9%FY 2025: 2.0%
FY 2016 5y median 12.8% FY 2025
ROIC 2.2%
FY 2016: 30.1%FY 2017: 16.3%FY 2018: 30.6%FY 2019: 25.1%FY 2020: 25.7%FY 2021: 27.4%FY 2022: 14.9%FY 2023: 11.1%FY 2024: 5.7%FY 2025: 2.2%
FY 2016 5y median 11.1% FY 2025
ROA 1.4%
FY 2016: 21.3%FY 2017: 12.0%FY 2018: 22.8%FY 2019: 19.4%FY 2020: 19.5%FY 2021: 20.2%FY 2022: 11.6%FY 2023: 10.1%FY 2024: 5.6%FY 2025: 1.4%
FY 2016 5y median 10.1% FY 2025

Growth (YoY)

Revenue 8.3%
FY 2016: 9.5%FY 2017: 4.1%FY 2018: 13.6%FY 2019: -10.8%FY 2020: 7.0%FY 2021: 4.6%FY 2022: -15.8%FY 2023: -7.8%FY 2024: -7.2%FY 2025: 8.3%
FY 2016 FY 2025
Operating Income -23.3%
FY 2016: -2.1%FY 2017: -4.4%FY 2018: 42.1%FY 2019: -22.4%FY 2020: 20.7%FY 2021: -3.6%FY 2022: -36.8%FY 2023: -13.5%FY 2024: -28.7%FY 2025: -23.3%
FY 2016 FY 2025
EPS (diluted) -73.5%
FY 2016: 11.1%FY 2017: -36.6%FY 2018: 102.4%FY 2019: -13.9%FY 2020: 32.9%FY 2021: -2.2%FY 2022: -37.3%FY 2023: -8.1%FY 2024: -33.6%FY 2025: -73.5%
FY 2016 FY 2025
Free Cash Flow -83.3%
FY 2016: 18.9%FY 2017: 6.0%FY 2018: 27.2%FY 2019: -21.7%FY 2020: 31.9%FY 2021: -25.4%FY 2022: -13.8%FY 2023: -40.0%FY 2024: -9.3%FY 2025: -83.3%
FY 2016 FY 2025

Financial Health

Current Ratio 2.2×
FY 2016: 2.0×FY 2017: 2.4×FY 2018: 2.6×FY 2019: 2.4×FY 2020: 2.5×FY 2021: 2.3×FY 2022: 2.7×FY 2023: 3.5×FY 2024: 2.0×FY 2025: 2.2×
FY 2016 5y median 2.3× FY 2025
Quick Ratio 1.4×
FY 2016: 1.5×FY 2017: 2.0×FY 2018: 2.1×FY 2019: 1.9×FY 2020: 2.0×FY 2021: 1.6×FY 2022: 2.2×FY 2023: 3.0×FY 2024: 1.5×FY 2025: 1.4×
FY 2016 5y median 1.6× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -1.8×
FY 2016: -1.2×FY 2017: -1.6×FY 2018: -1.0×FY 2019: -1.2×FY 2020: -1.5×FY 2021: -1.2×FY 2022: -2.1×FY 2023: -2.6×FY 2024: -1.4×FY 2025: -1.8×
FY 2016 5y median -1.8× FY 2025
Interest Coverage 60.4×
FY 2016: 312×FY 2017: 2881×FY 2018: 5232×FY 2019: 2215×FY 2020: 348×FY 2021: 2986×FY 2022: 560×FY 2023: 355×FY 2024: 236×FY 2025: 60.4×
FY 2016 5y median 355× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2026-01-03